You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis D

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

Recruiting
  • Chronic Hepatitis D
    • Moscow, Russian Federation
      Center of Target Therapy
    Nov 6, 2023

    Safety and Biomarkers of Bulevirtide Treatment in Chronic

    Recruiting
    • Chronic Hepatitis D
    • Stockholm, Sweden
      Karolinska University Hospital, Department of Infectious Disease
    Sep 27, 2023

    Chronic Hepatitis D Infection Trial in Changchun (Hepalatide, Hepalatide Placebo)

    Not yet recruiting
    • Chronic Hepatitis D Infection
    • Changchun, China
      The first hospital of Jilin University
    Apr 22, 2023

    Patient Knowledge, Beliefs and Barriers to Hepatitis D Care

    Not yet recruiting
    • Hepatitis, Delta
    • Questionnaire based intervention
    • (no location specified)
    Aug 29, 2023

    Hepatitis D Trial in Athens (Bulevirtide)

    Recruiting
    • Hepatitis D
    • Athens, Greece
      Department of Gastroenterology, Medical School of National & Kap
    Jun 28, 2023

    Chronic Hepatitis D Infection Trial (Bulevirtide)

    Not yet recruiting
    • Chronic Hepatitis D Infection
    • Bulevirtide
    • (no location specified)
    Jan 30, 2023

    Standardising Care for Hepatitis Delta in the Netherlands

    Not yet recruiting
    • Hepatitis D
      • (no location specified)
      Jun 6, 2023

      Burden of Hepatitis D Virus Infection in China Through

      Not yet recruiting
      • Hepatitis D
      • +3 more
      • HDV-Ab (IgG), HDV-RNA, RNA genotype
      • (no location specified)
      Nov 1, 2022

      Bulevirtide Therapy in Chronic Hepatitis Delta in Italy

      Recruiting
      • Hepatitis D
      • Milan, MI, Italy
        Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
      Nov 7, 2023

      Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

      Active, not recruiting
      • Chronic Hepatitis B and Hepatitis D Co-infection
      • HH-003 20mg/kg
      • HH-003 3mg/kg
      • Changchun, Jilin, China
        First Hospital of Jilin University
      Dec 30, 2022

      Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate

      Not yet recruiting
      • Chronic Viral Hepatitis B With Delta-Agent
        • Esik, Almaty Region, Kazakhstan
        • +6 more
        Oct 3, 2023

        Hepatitis D, Chronic Trial in Auckland (VIR-2218, VIR-3434)

        Not yet recruiting
        • Hepatitis D, Chronic
        • Auckland, New Zealand
          Investigative Site
        Jul 12, 2022

        Bulevirtide Therapy in HDV Chronic Hepatitis in Italy

        Completed
        • Hepatitis D
        • Milan, MI, Italy
          Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
        Jul 24, 2023

        DELTA DESCRIBE: THE FRENCH COLLABORATIVE PROJECT

        Recruiting
        • Hepatitis D
        • Patients co-infected HBV/HDV
        • Limoges, France
          Chu Limoges
        Jun 27, 2023

        Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

        Terminated
        • Hepatitis B, Chronic
        • Hepatitis D
        • Chisinau, Republic Of Moldova, Moldova, Republic of
        • +1 more
        Nov 15, 2022

        Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

        Not yet recruiting
        • Chronic Hepatitis Delta
        • Peginterferon Lambda
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 25, 2023

        Patients With Hepatitis D Virus (HDV) Infection in China

        Not yet recruiting
        • Hepatitis D
          • Beijing, Beijing, China
            Bejing Tsinghua Changgung Hospital
          Jul 7, 2022

          Evaluation of Patients With Liver Disease

          Recruiting
          • Hepatitis D
          • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            Chronic Delta Hepatitis Trial (lonafarnib, Ritonavir)

            Completed
            • Chronic Delta Hepatitis
            • (no location specified)
            Dec 12, 2022

            Chronic Hepatitis D Infection Trial (Bulevirtide)

            Not yet recruiting
            • Chronic Hepatitis D Infection
            • Bulevirtide
            • (no location specified)
            Mar 1, 2023

            Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

            Completed
            Has Results
            • Hepatitis D, Chronic
            • Peginterferon Lambda-1A
            • Beersheba, Israel
            • +3 more
            Dec 20, 2022

            Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

            Not yet recruiting
            • Chronic Hepatitis Delta Virus Infection
            • HH-003(20mg/kg)
            • +2 more
            • (no location specified)
            May 7, 2023

            COVID-19 Vaccination and Prevalence of COVID-19 in Chronic Liver

            Not yet recruiting
            • Chronic or Recovered Hepatitis B
            • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Feb 2, 2023

              Burden of Hepatitis D Virus (HDV) Infection in Italy

              Recruiting
              • Chronic Hepatitis D
                • Bari, Italy
                • +35 more
                Feb 1, 2023

                Hepatitis D, Chronic Trial in Be'er Sheva, Auckland, Istanbul (Lonafarnib, Ritonavir)

                Recruiting
                • Hepatitis D, Chronic
                • Be'er Sheva, Israel
                • +2 more
                Jan 27, 2022